Evidence map›Paper›PMID 28396177›Full record

ArticleJournal of neuroscience methods2017

Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair.

Jonathan P C Hasselmann, Hawra Karim, Anna J Khalaj, Subir Ghosh, Seema K Tiwari-Woodruff

Abstract read
In one paragraph

Article in Journal of neuroscience methods, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jonathan P C HasselmannDivision of Biomedical Sciences, UCR School of Medicine, Riverside, CA 92521, USA.
Hawra KarimDivision of Biomedical Sciences, UCR School of Medicine, Riverside, CA 92521, USA.
Anna J KhalajDivision of Biomedical Sciences, UCR School of Medicine, Riverside, CA 92521, USA.
Subir GhoshDepartment of Statistics, UCR-CNAS, Riverside, CA 92521, USA.
Seema K Tiwari-WoodruffDivision of Biomedical Sciences, UCR School of Medicine, Riverside, CA 92521, USA; Department of Neuroscience, UCR School of Medicine, Riverside, CA 92521, USA; Center for Glial-Neuronal Interactions, UCR School of Medicine, CA 92506, USA. Electronic address: seema.tiwari-woodruff@medsch.ucr.edu.
University of California, Riverside · US

Funding

Stimulating oligodendrocyte progenitor cell differentiation and remyelinationR01NS081141 · NINDS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI TIWARI-WOODRUFF, SEEMA K · 2014 to 2017
$1.3M
Estrogen receptor B ligand: A novel treatment to enhance functional remyelinationR21NS075198 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TIWARI-WOODRUFF, SEEMA K · 2011 to 2012
$424k
NINDS NIH HHS R01 NS081141NINDS NIH HHS R21 NS075198
6 · The paper itself

Abstract

backgroundWhile many groups use experimental autoimmune encephalomyelitis (EAE) as a model to uncover therapeutic targets and understand the pathology underlying multiple sclerosis (MS), EAE protocol variability introduces discrepancies in central nervous system (CNS) pathogenesis and clinical disease, limiting the comparability between studies and slowing much-needed translational research. OPTIMIZED

methodHere we describe a detailed, reliable protocol for chronic EAE induction in C57BL/6 mice utilizing two injections of myelin oligodendrocyte glycoprotein (35-55) peptide mixed with complete Freund's adjuvant and paired with pertussis toxin.

resultsThe active MOG COMPARISON WITH EXISTING METHOD(S): Lack of detailed protocols, combined with variability between laboratories, make EAE results difficult to compare and hinder the use of this model for therapeutic development. We provide the most detailed active MOG

conclusionsBy providing a detailed active MOG

Indexed as

Disease Models, AnimalFreund's AdjuvantMyelin-Oligodendrocyte GlycoproteinAnimalsDrug CombinationsEncephalomyelitis, Autoimmune, ExperimentalFemaleHumansLongitudinal StudiesMiceMice, Inbred C57BLMultiple SclerosisPeptide FragmentsReproducibility of ResultsSensitivity and SpecificityTreatment OutcomeDrug CombinationsFreund's AdjuvantMyelin-Oligodendrocyte Glycoproteinmyelin oligodendrocyte glycoprotein (35-50), Ala(37)-Peptide FragmentsAutoimmuneBrainClinical scoreDemyelinationExperimental autoimmune encephalomyelitis (EAE)Immune cellsImmunohistochemistryInfiltrationInflammatory cellsMOG(35-55)Mouse models of multiple sclerosisMultiple sclerosis (MS)Myelin basic proteinNeurodegenerationPertussis toxinSpinal cord

Identifiers

PMID28396177
PMCPMC5749979
OpenAlexW2605033539

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.